OmniVis

OmniVis

OmniVis logo

OmniVis is a biotechnology company that specializes in the development of portable diagnostic devices for the rapid detection of infectious diseases. The company is known for its innovative approach to disease detection, utilizing advanced technology to provide quick and accurate results in various settings, including remote and resource-limited areas.

History

OmniVis was founded with the mission to improve global health by providing accessible and affordable diagnostic solutions. The company emerged from research conducted at Purdue University, where the founders developed a novel method for detecting pathogens using a combination of microfluidics and smartphone technology.

Technology

OmniVis's technology is centered around a handheld device that leverages microfluidics and smartphone integration to detect pathogens such as Vibrio cholerae, the bacterium responsible for cholera. The device uses a disposable cartridge where a sample is mixed with reagents, and the reaction is analyzed using the smartphone's camera and processing power. This method allows for rapid detection, often within 30 minutes, making it ideal for use in field conditions.

Microfluidics

Microfluidics involves the manipulation of small volumes of fluids, typically in the range of microliters, in channels with dimensions of tens to hundreds of micrometers. This technology is crucial for OmniVis's device as it enables precise control and analysis of the sample and reagents, leading to accurate detection of pathogens.

Smartphone Integration

The integration of smartphone technology allows OmniVis's device to be both portable and user-friendly. The smartphone acts as the interface for the device, providing a platform for data analysis and display. This integration also facilitates data sharing and connectivity, which is essential for tracking disease outbreaks and coordinating public health responses.

Applications

OmniVis's diagnostic device is primarily used for the detection of cholera, a disease that poses significant public health challenges in many parts of the world. The device's portability and rapid results make it particularly useful in outbreak situations, where timely diagnosis is critical for effective intervention.

Awards and Recognition

TechCrunch Disrupt San Francisco 2019

OmniVis has received numerous accolades for its innovative technology and impact on global health. The company has been recognized at various technology and innovation conferences, including TechCrunch Disrupt, where it showcased its device and received positive attention from both the public and industry experts.

Future Developments

OmniVis continues to expand its technology to detect other pathogens and diseases. The company is exploring applications in detecting other waterborne diseases and expanding its diagnostic capabilities to include viral and bacterial infections beyond cholera.

Related Pages

• Microfluidics
• Cholera
• Biotechnology
• Smartphone